I. Frank

M. Prosperi, I. Frank, C. Torti, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A Tale of 2 Epidemics: The Intersection Between Obesity and HIV Infection in Philadelphia

M. Synnestvedt, R. Gross, I. Frank, 2005, Journal of acquired immune deficiency syndromes.

Outcomes of HIV-Infected Patients Receiving Care at Multiple Clinics

J. Metlay, R. Gross, I. Frank, 2014, AIDS and Behavior.

I. Frank, A. Tershakovec, Daniel Rader, 2004, Atherosclerosis.

Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial

J. Mascola, D. Montefiori, R. Bailer, 2017, PLoS medicine.

Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial

R. Grant, I. Frank, M. Murray, 2018, HIV clinical trials.

Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants

D. Dunbar, I. Frank, H. Tieu, 2018, AIDS and Behavior.

IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

M. Thomson, Feng-xiang Wang, E. Argyris, 2005, The Journal of clinical investigation.

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women

I. Frank, K. Mayer, C. Hendrix, 2017, Annals of Internal Medicine.

Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)

I. Frank, K. Mayer, C. Hendrix, 2016, The Journal of infectious diseases.

Didanosine Compared with Continuation of Zidovudine in HIV-infected Patients with Signs of Clinical Deterioration While Receiving Zidovudine

A. Cross, D. Peterson, I. Frank, 1994, Annals of Internal Medicine.

Long-term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients.

D. Rubin, I. Frank, S. Sinclair, 1989, The British journal of ophthalmology.

Perforin Expression Directly Ex Vivo by HIV-Specific CD8+ T-Cells Is a Correlate of HIV Elite Control

F. Pereyra, B. Walker, M. Lederman, 2010, PLoS pathogens.

Multiple Autoimmune-Associated Variants Confer Decreased IL-2R Signaling in CD4+CD25hi T Cells of Type 1 Diabetic and Multiple Sclerosis Patients

Elizabeth Whalen, Ian Frank, I. Frank, 2013, PloS one.

Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes

H. Friedman, I. Frank, G. Dubin, 1990, Journal of virology.

Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease.

D. Monos, G. Trinchieri, I. Frank, 1997, The Journal of clinical investigation.

The Identity of Human Tissue-Emigrant CD8+ T Cells

E. Wherry, A. Bar-Or, L. Picker, 2020, Cell.

Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.

D. Douek, J. Brenchley, A. Khoruts, 2008, Blood.

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.

Donald K Carter, Ian Frank, Beryl Koblin, 2013, The Journal of infectious diseases.

Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals.

Emily S. Charlson, F. Bushman, G. Weinstock, 2015, American journal of respiratory and critical care medicine.

Disruption of Intestinal CD4+ T Cell Homeostasis Is a Key Marker of Systemic CD4+ T Cell Activation in HIV-Infected Individuals

G. Ginsberg, I. Frank, G. Silvestri, 2010, The Journal of Immunology.

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)

J. Fuchs, S. Kalams, N. Frahm, 2015, Open forum infectious diseases.

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination.

Zoe Moodie, Ian Frank, M Juliana McElrath, 2007, Journal of immunological methods.

A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.

R. McKinnis, I. Frank, R. Murphy, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

J. Kublin, D. Montefiori, H. Schuitemaker, 2020, The lancet. HIV.

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells

D. Hazuda, D. Richman, J. Martinez-Picado, 2018, Science Translational Medicine.

An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).

D. Mehrotra, P. Gilbert, I. Frank, 2011, The Journal of infectious diseases.

Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.

R. Eisenberg, G. Cohen, H. Friedman, 1990, The Journal of infectious diseases.

Critical for Immune Control of HIV-1 Restricted by Protective HLA Alleles Is Preservation of T Cell Proliferation

M. McElrath, I. Frank, Yunda Huang, 2012 .

Preservation of T Cell Proliferation Restricted by Protective HLA Alleles Is Critical for Immune Control of HIV-1 Infection1

M. McElrath, I. Frank, Yunda Huang, 2006, The Journal of Immunology.

Infection Critical for Immune Control of HIV-1 Restricted by Protective HLA Alleles Is Preservation of T Cell Proliferation

M. McElrath, I. Frank, S. C. Rosa, 2006 .

Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.

Shuntai Zhou, R. Swanstrom, I. Frank, 2016, The Journal of infectious diseases.

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

I. Frank, P. Tebas, T. Kenney, 2010, AIDS.

Impaired interleukin 12 production in human immunodeficiency virus- infected patients

G. Trinchieri, I. Frank, Xiaojing Ma, 1994, The Journal of experimental medicine.

Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1

R. Siliciano, L. Montaner, K. Mounzer, 2020, Proceedings of the National Academy of Sciences.

Recommendations for measuring HIV reservoir size in cure-directed clinical trials

R. Siliciano, F. Bushman, D. Hazuda, 2020, Nature medicine.

Peripheral blood Dendritic cells are not a major reservoir for HIV type 1 in infected individuals on virally suppressive HAART.

Feng-xiang Wang, I. Frank, R. Pomerantz, 2003, AIDS research and human retroviruses.

Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.

Karen L. Price, J. Ramirez, D. Skovronsky, 2021, JAMA.

Overestimates of Survival after HAART: Implications for Global Scale-Up Efforts

R. Gross, I. Frank, D. Dickinson, 2008, PloS one.

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

B. Strom, R. Gross, I. Frank, 2006, AIDS.

Antiretroviral Failure Despite High Levels of Adherence: Discordant Adherence-Response Relationship in Botswana

R. Gross, I. Frank, G. Bisson, 2008, Journal of acquired immune deficiency syndromes.

First and Second Line Highly Active Anti-Retroviral Therapy Failure in HIV Infected Nigerian Children at University of Abuja Teaching Hospital, Nigeria

I. Frank, A. Okechukwu, Amajuoyi, 2016 .

Acceptability of the Human Papillomavirus Vaccine Among Urban Adolescent Males

I. Frank, K. Jones, A. Leader, 2013, American journal of men's health.

Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy

I. Frank, R. Collman, D. A. Hill, 2022, AIDS.

Improved Immunogenicity With High-Dose Seasonal Influenza Vaccine in HIV-Infected Persons

I. Frank, Deborah Kim, P. Tebas, 2013, Annals of Internal Medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients.

B. Levine, I. Frank, J. Dai, 2008, Virology.

Identification and characterization of HIV-specific resident memory CD8+ T cells in human lymphoid tissue

E. Wherry, D. Douek, M. Betts, 2018, Science Immunology.

Role of CXCR4 in Cell-Cell Fusion and Infection of Monocyte-Derived Macrophages by Primary Human Immunodeficiency Virus Type 1 (HIV-1) Strains: Two Distinct Mechanisms of HIV-1 Dual Tropism

E. De Clercq, D. Kolson, I. Frank, 1999, Journal of Virology.

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.

Allan C. deCamp, S. Hammer, J. Mascola, 2019, The Journal of clinical investigation.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Lindsay N. Carpp, Vicki C. Ashley, Allan C. deCamp, 2022 .

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

Holly Janes, David C Montefiori, Peter B Gilbert, 2013, The New England journal of medicine.

CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection 1

Daniel C. Douek, Ian Frank, Nichole R. Klatt, 2008, The Journal of Immunology.

Mucosal immune dysfunction in AIDS pathogenesis.

C. Apetrei, I. Pandrea, I. Frank, 2008, AIDS reviews.

Correlation between Interferon-γ Secretion and Cytotoxicity, in Virus-Specific Memory T Cells

M. Hudgens, M. McElrath, N. Russell, 2004 .

Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248)

M. Lederman, R. Gelman, K. Squires, 2004, Journal of acquired immune deficiency syndromes.

mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern

Aaron M. Rosenfeld, Justine C. Williams, E. Wherry, 2021, bioRxiv.

Long-term outpatient treatment of CMVretinitis with ganciclovir in AIDS patients The CMV

D. Rubin, I. Frank, S. Sinclair, 2022 .

Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humans

Ian Frank, Neha Vapiwala, I. Frank, 2008, Cancer biology & therapy.

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared to SARS-CoV-2 mRNA vaccinations

D. Rader, E. Wherry, J. Weaver, 2021, medRxiv.

Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study

J. Kublin, D. Montefiori, O. Hyrien, 2021, PLoS medicine.

Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19

E. Wherry, L. Rauova, A. Greenplate, 2022, Frontiers in Immunology.

HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic

Philip Smith, L. Montaner, C. Voytek, 2021, AIDS and Behavior.

A retrospective study of HIV pre‐exposure prophylaxis counselling among non‐Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014–2019

R. Gross, I. Frank, Sarah M. Wood, 2022, Journal of the International AIDS Society.

Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials

R. Gross, Danielle Fiore, I. Frank, 2020, AIDS and Behavior.

Once-daily antiretroviral therapies for HIV infection: Consensus statement of an Advisory Committee of the International Association of Physicians in AIDS Care

K. Squires, I. Frank, P. Tebas, 2002, Journal of the International Association of Physicians in AIDS Care.

lentiviral infections Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic

D. Douek, J. Brenchley, A. Khoruts, 2013 .

Individuals T Cell Activation in HIV-Infected + CD4Homeostasis Is a Key Marker of Systemic T Cell + Disruption of Intestinal CD4

G. Ginsberg, I. Frank, G. Silvestri, 2010 .

Associations among Race/Ethnicity, ApoC-III Genotypes, and Lipids in HIV-1-Infected Individuals on Antiretroviral Therapy

M. Reilly, E. Puleo, I. Frank, 2006, PLoS medicine.

Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV Implications for Treatment and Research

R. Tyndale, K. Mounzer, R. Gross, 2018, Journal of acquired immune deficiency syndromes.

Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?

S. Ratcliffe, R. Gross, D. Kolson, 2018, Journal of the International Association of Providers of AIDS Care.

Feasibility of Identifying a Cohort of US Women at High Risk for HIV Infection for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 906

D. Dunbar, I. Frank, B. Koblin, 2013, Journal of acquired immune deficiency syndromes.

Recruitment of Urban US Women at Risk for HIV Infection and Willingness to Participate in Future HIV Vaccine Trials

D. Dunbar, D. Metzger, I. Frank, 2013, AIDS and Behavior.

A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G

H. Friedman, I. Frank, Ian Frank, 1989, Journal of virology.

Appropriateness of antiretroviral therapy in clients of an HIV/AIDS case management organization

I. Frank, W. Holmes, J. Pace, 2007, AIDS care.

The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV

S. Siegel, K. Mounzer, R. Gross, 2017, Journal of NeuroVirology.

Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions

Judith A. Long, B. French, I. Frank, 2012, AIDS care.

Antivirals against HIV-1.

I. Frank, 2002, Clinics in laboratory medicine.

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers

B. Abella, P. Gimotty, S. Hensley, 2020, JAMA internal medicine.

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial

B. Abella, P. Gimotty, S. Hensley, 2020 .

Effects of a Health Promotion Intervention on Physical Activity in African American Men Living with HIV: Randomized Controlled Trial

I. Frank, S. Bellamy, L. Jemmott, 2021, AIDS patient care and STDs.

An unusual syncytia-inducing human immunodeficiency virus type 1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis

D. Kolson, I. Frank, R. Collman, 2003, Journal of NeuroVirology.

IL-15 enhances immune functions during HIV infection.

I. Frank, S. Chouaib, D. Bacheller, 1997, Journal of immunology.

Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19

O. Hyrien, I. Frank, G. Tomaras, 2022, JCI insight.

Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

I. Frank, P. Goepfert, S. Gurunathan, 2021, The Lancet Infectious Diseases.

Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.

D. Montefiori, I. Frank, G. Ferrari, 2023, Vaccine.

Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals.

H. Friedman, I. Frank, G. Dubin, 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Awareness of HPV and Uptake of Vaccination in a High-Risk Population

I. Frank, J. Fishman, L. Taylor, 2016, Pediatrics.

An Exploratory Study of Adolescent Female Reactions to Direct-to-Consumer Advertising: The Case of the Human Papillomavirus (HPV) Vaccine

Bridgette M. Brawner, C. Voytek, I. Frank, 2011, Health marketing quarterly.

Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.

K. Mounzer, R. Gross, I. Frank, 2019, Drug and alcohol dependence.

DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA

R. Gottardo, N. Frahm, Greg Finak, 2017, Clinical and Vaccine Immunology.

Effect of GB virus C viremia on HIV acquisition and HIV set-point

D. Weissman, B. Strom, J. Kostman, 2005, AIDS.

Priming for high interferon-gamma production induced by interleukin-12 in both CD4+ and CD8+ T cell clones from HIV-infected patients.

G. Trinchieri, I. Frank, G Trinchieri, 1995, The Journal of clinical investigation.

Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)

I. Frank, C. Hendrix, M. Marzinke, 2022, AIDS and Behavior.

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial

D. Montefiori, G. Pantaleo, M. McElrath, 2019, The Journal of clinical investigation.

Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals

Angela K. Shen, I. Frank, P. Offit, 2021, JAMA network open.

Parent and Adolescent Knowledge of HPV and Subsequent Vaccination

I. Frank, J. Fishman, L. Taylor, 2014, Pediatrics.

HIV infection and glycemic response to newly initiated diabetic medical therapy

I. Frank, S. Bellamy, G. Bisson, 2012, AIDS.

The Development of a Culturally Relevant, Theoretically Driven HPV Prevention Intervention for Urban Adolescent Females and Their Parents/Guardians

Bridgette M. Brawner, C. Voytek, I. Frank, 2013, Health promotion practice.

Mapping the Lineage Relationship between CXCR5+ and CXCR5− CD4+ T Cells in HIV-Infected Human Lymph Nodes

G. Reyes-Terán, I. Frank, A. Naji, 2019, Cell reports.

Mapping the Lineage Relationship between CXCR5+ and CXCR5− CD4+ T Cells in HIV-Infected Human Lymph Nodes

G. Reyes-Terán, I. Frank, A. Naji, 2019, bioRxiv.

Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells.

I. Frank, P. Tebas, J. Boyer, 2014, The Journal of infectious diseases.

Directly Associated with Baseline frequency of Naïve T-Cells

I. Frank, P. Tebas, J. Boyer, 2014 .

Performance characteristics of the Cavidi ExaVir viral load assay and the ultra-sensitive P24 assay relative to the Roche Monitor HIV-1 RNA assay.

R. Bosch, I. Frank, J. Eron, 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity

D. Rader, E. Wherry, J. Weaver, 2021, medRxiv.

Evidence that intermittent structured treatment interruption, but not immunization with ALVAC-HIV vCP1452, promotes host control of HIV replication: the results of AIDS Clinical Trials Group 5068.

V. Johnson, M. Saag, I. Frank, 2006, The Journal of infectious diseases.

Development of a Human Neuronal Cell Model for Human Immunodeficiency Virus (HIV)-Infected Macrophage-Induced Neurotoxicity: Apoptosis Induced by HIV Type 1 Primary Isolates and Evidence for Involvement of the Bcl-2/Bcl-xL-Sensitive Intrinsic Apoptosis Pathway

D. Kolson, I. Frank, S. Jaffer, 2002, Journal of Virology.

Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV

L. Montaner, D. Metzger, I. Frank, 2013, AIDS care.

Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.

I. Frank, K. Mayer, C. Hendrix, 2021, AIDS.

Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity

H. Friedman, I. Frank, G. Dubin, 1991, Journal of virology.

Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro.

M. Rayner, I. Frank, F. González-Scarano, 2000, AIDS research and human retroviruses.

The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine.

R. Bosch, I. Frank, J. Eron, 2007, Journal of acquired immune deficiency syndromes.

Patients in transition: avoiding detours on the road to HIV treatment success

I. Frank, B. Yehia, S. Kangovi, 2013, AIDS.

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

Allan C. deCamp, J. Mullins, J. Weiner, 2023, EBioMedicine.

Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial

E. Kerwin, J. Tomassini, I. Frank, 2021, medRxiv.

HIV Sexual Risk and Syndemics among Women in Three Urban Areas in the United States: Analysis from HVTN 906

V. Frye, D. Dunbar, I. Frank, 2015, Journal of Urban Health.

SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations

D. Rader, E. Wherry, J. Weaver, 2022, Cell Reports.

Neurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.

M. Lederman, C. Yiannoutsos, K. Marder, 1999, AIDS.

Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection

A. Adimora, Steven Wolinsky, S. Gange, 2023, bioRxiv.

Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.

R. Lenkinski, I. Frank, D. Lopez-Villegas, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells.

M. Hudgens, M. McElrath, N. Russell, 2004, Journal of Infectious Diseases.

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.

J. Kublin, J. Fuchs, N. Sardesai, 2013, The Journal of infectious diseases.

Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals.

Emily S. Charlson, F. Bushman, G. Weinstock, 2015, American journal of respiratory and critical care medicine.

D. Weissman, R. Gross, I. Frank, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Lindsay N. Carpp, Vicki C. Ashley, Allan C. deCamp, 2018, The Journal of infectious diseases.

Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era.

A. Praestgaard, J. Kostman, R. Gross, 2012, Journal of pain and symptom management.

HIV post-treatment controllers have distinct immunological and virological features

R. Schooley, M. Lederman, D. Havlir, 2023, Proceedings of the National Academy of Sciences of the United States of America.

This information is current as during HIV Infection Cell Subsets That Are Differentially Depleted T + CD 127 and CD 25 Expression Defines CD 4

D. Douek, J. Brenchley, A. Weintrob, 2008 .

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

Allan C. deCamp, J. Mullins, J. Weiner, 2023, EBioMedicine.

Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.

J. Gallant, R. Grant, I. Frank, 2017, The lancet. HIV.